Related Experiment Video

Updated: Jun 25, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Role of cardiac resynchronization therapy in asymptomatic and mildly symptomatic heart failure

Matthew S Forcina1, Michael R Gold

  • 1Medical University of South Carolina, 25 Courtenay Drive, Charleston, SC 29425, USA.

Current Heart Failure Reports
|March 7, 2009
PubMed

Insights

Cardiac resynchronization therapy (CRT) benefits patients with moderate to severe congestive heart failure (CHF). New research shows CRT also improves heart function and delays hospitalizations in mild CHF patients.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Cardiac Electrophysiology

Background:

  • Cardiac resynchronization therapy (CRT) is established for moderate to severe congestive heart failure (CHF) with reduced ejection fraction and QRS prolongation.
  • Evidence for CRT benefits in minimal or mild CHF patients is limited, with prior studies showing mixed results on remodeling and symptoms.

Purpose of the Study:

  • To investigate the effects of CRT on left ventricular (LV) remodeling, function, and clinical outcomes in asymptomatic or mildly symptomatic CHF patients.
  • To evaluate if CRT offers benefits beyond reverse remodeling in this patient subgroup.

Main Methods:

  • A recent, larger study involving asymptomatic or mildly symptomatic CHF patients with specific cardiac criteria.
  • Longer follow-up period compared to previous investigations.
  • Assessment of LV size, LV function, and time to heart failure hospitalization.

Main Results:

  • CRT demonstrated a confirmed beneficial effect on LV size and function in this population.
  • The study was the first to show that CRT improves clinical outcomes by delaying heart failure hospitalizations.
  • Reverse remodeling was observed, but symptomatic improvement data was not the primary focus.

Conclusions:

  • CRT offers significant benefits for LV remodeling and function in asymptomatic or mildly symptomatic CHF patients.
  • CRT improves clinical outcomes in this group, primarily by delaying heart failure hospitalizations.
  • Ongoing trials are expected to provide further data on CRT's impact on morbidity and mortality in milder CHF cases.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae07:51

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae

Published on: February 17, 2023

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...